Minocycline-induced pigmentation occurring in two sisters

Area of Science:

• Dermatology
• Pharmacology

Background:

• Acne vulgaris is a common skin condition often treated with antibiotics like minocycline.
• Minocycline is a tetracycline antibiotic with known side effects, though hyperpigmentation is uncommon.

Observation:

• Two sisters developed facial pigmentation while undergoing treatment for acne vulgaris.
• Both patients were concurrently using minocycline and Dianette (containing ethinyloestradiol).

Findings:

• Facial hyperpigmentation in these cases may stem from altered minocycline metabolism due to genetic predisposition.
• The ethinyloestradiol component of Dianette could potentially contribute to or exacerbate minocycline-induced pigmentation.

Implications:

• Patients prescribed minocycline, particularly those on combined therapies, require regular monitoring for skin hyperpigmentation.
• Healthcare providers should consider potential drug interactions and individual metabolic factors when prescribing minocycline for acne.
• Early detection of hyperpigmentation is crucial for managing this adverse effect of minocycline therapy.